ev3 Inc.
Endovascular-focused medical device company reports second quarter net sales
Published in Cardiovascular Business Week, August 9th, 2005
ev3's net sales in the second quarter of 2005 were $31.5 million, an increase of 53% versus net sales of $20.6 million in the second quarter of 2004, and an increase of 14% compared to net sales of $27.7 million in the first quarter of 2005. This growth was generated internally and reflected net sales growth in each of ev3's reportable business segments and geographic markets.
By segment, ev3's second quarter net sales of cardio peripheral products were $19.2 million, representing an increase of 58% versus the year-ago...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- CoreValve
Heart valve company completes $24 million series B round of financing - CryoCor, Inc.
Cryoablation company announces pricing of initial public offering - RegeneRx Biopharmaceuticals, Inc.
Biopharmaceutical company joins new Russell Microcap Index - Solvay
Final purchase agreement to buy Fournier Pharma finalized for 100% of company - Spectranetics Corporation
Single-use medical devices company listed on new Russell Microcap Index - SPO Medical Inc.
Biosensor, microproccessor developer completes reverse acquisition transaction - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
